U.S. Stock News

First Hawaiian stock has delivered a strong 55.3% gain over the past 3 years, yet recent short term weakness now meets a set of valuation checks that broadly suggest the shares still lean on the cheap side. A 55.3% return over 3 years signals that First Hawaiian has already rewarded patient shareholders, so the key issue is whether that strength has already been fully reflected in the current share price. The bank's earnings power and balance sheet quality can support the current valuation,...

A proposed merger between Union Pacific and Norfolk Southern (NSC) is under review by the Surface Transportation Board, with a decision expected in 2027. The stock now trades around $352.68. For investors trying to put this in context, Norfolk Southern’s recent momentum has been strong, with a 14.55% 90 day share price return and 22.53% year to date share price return translating into a 31.78% 1 year total shareholder return. This points to building optimism around the stock as the merger...

Intellia Therapeutics stock has rebounded over the past year, yet its longer term track record and current valuation checks point to a much less flattering picture. The current market pricing appears rich compared with the broader fundamentals scorecard and the long run return profile. Over the past 5 years, Intellia Therapeutics shareholders have seen the stock fall about 92%, which puts a spotlight on how much long term value the market believes is still on the table. Future progress on...

Semtech surged 10.4% to US$140.80 by the close, which indicates traders reacted positively to the results. The bigger story sits behind the pop. After a run of choppy quarters, Q2 FY2027 swung to Basic EPS of US$1.72 on revenue of US$341.9m, a sharp contrast with the prior year’s Q2 loss. For a semiconductor stock that had a weak 90 day stretch coming into this report, that level of earnings power was the key driver of today’s move. The question now is whether this profit swing is a one...

Innospec stock has delivered a solid 25.4% gain year to date, while valuation checks send mixed messages as the intrinsic value estimate points to upside and market multiples lean the other way. The 25.4% year to date return suggests investors have already priced in a better outlook. The key issue is how much optimism is now embedded in Innospec shares. Future cash flow growth from Innospec's specialty chemicals portfolio may support the intrinsic value case, but any pressure on margins or...

Zoom Communications stock just dropped 7% in a day, yet the headline number that actually hit the tape was a punchy Q2 profit story. Revenue came in at about US$1.28b and non GAAP operating margin held at a hefty 40%. The emotional reset is happening in the valuation, not in the income statement. Coming into the print, Zoom was already down over the past quarter and trading on a single digit P/E compared with much richer software peers. Today's selloff looks less like a collapse in the video...

Box stock barely budged after earnings, up about 1% to US$33.39, even though the latest quarter delivered what many software investors usually cheer. Revenue reached US$321.1 million and non GAAP earnings per share came in at US$0.40, with operating margin at 29.4%. The short term reaction looks muted for a stock that has already climbed more than 30% over the past three months. The real question for you now is whether that quiet move hides a bigger story in Box’s multi year earnings...

Wingstop (WING) stock is in focus after the company highlighted international progress in the UK and Ireland, including its 100th restaurant opening and plans for up to 30 additional sites this year. Wingstop shares have faced heavy selling pressure, with the 30 day share price return down 18.22% and the year to date share price return down 56.30%, while the 1 year total shareholder return has declined 66.66%. This suggests that recent international milestones and the announced departure of a...

John Wiley & Sons (WLY) has launched a new spectral analysis API portfolio that plugs its scientific databases and algorithms directly into lab and software workflows. For investors, this product shift raises fresh questions about the stock’s role in research technology. Over the past year, John Wiley & Sons has seen a strong shift in sentiment, with the share price delivering an 80.03% year to date share price return and a 27.48% 90 day share price return. The 1 year total shareholder return...

SouthState Bank (SSB) has moved into Government Contractor Banking and named veteran banker David Mathis to lead the new vertical. This niche expansion gives investors fresh context for assessing the stock. SouthState Bank’s latest move comes after a period where momentum has generally been building, with a 90-day share price return of 12.32% and a 1-year total shareholder return of 7.15%, alongside solid multi year total shareholder returns over three and five years. Compare SouthState...

Generac Holdings (GNRC) is drawing attention after highlighting a growing data center opportunity, including a reported US$1.6b backlog and nearly US$700m of committed 2027 volume from a single hyperscale customer. Against this backdrop, Generac Holdings’ share price has been volatile, with a 1-day share price return of 2.40% and a 30-day share price return of 4.60%, while the 90-day share price return fell 26.06% and the year-to-date share price return is 46.44%. Compare Generac Holdings’...

MSCI is reviewing potential rule changes that could lead to the removal of Strategy (NasdaqGS:MSTR) from its global equity indexes. The index provider is assessing whether Strategy's focus on asset accumulation rather than operating businesses fits its equity index criteria. Possible exclusion from MSCI's global equity indexes raises questions about future liquidity and institutional ownership for Strategy stock. The review is especially important because Strategy's business model is closely...

Earlier this week, MP Materials announced a multi-year, nine-figure agreement to supply gadolinium oxide to a major U.S. aerospace and defense manufacturer, underscoring its role in the domestic rare-earths supply chain alongside existing commitments from the Department of Defense and Apple. This deal signals MP Materials’ push beyond mining into higher-value rare-earth products, potentially deepening its integration into U.S. defense and advanced manufacturing ecosystems. We’ll now examine...

CACI International (CACI) has drawn fresh attention after opening a 61,000 square foot Manufacturing Center of Excellence for defense electronics near Rochester, New York, expanding its capacity for electronic warfare systems. The Rochester facility opening comes as CACI International’s stock trades at US$624.74, with a 30-day share price return of 25.98% and a 19.49% share price return over 90 days. The 1-year total shareholder return of 28.26% and 3-year total shareholder return of 90.08%...

StoneCo Ltd. recently reported its second-quarter 2026 results, with revenue rising to R$3,587.38 million from R$3,500.92 million a year earlier, while quarterly net income eased to R$444.59 million from R$598.51 million. Despite the softer quarter, StoneCo’s net income for the first half of 2026 climbed to R$2.15 billion from R$1.11 billion, pointing to much stronger profitability over the six-month period. With first-half net income reaching R$2.15 billion, we’ll now examine how this...

Strattec Security just saw its stock drop almost 8% in a single session, yet the headline from this quarter is not collapse; it is pressure. The company posted Q4 revenue of US$151.8 million with basic earnings per share of about US$0.96, and investors reacted by marking down a stock that already trades on a trailing P/E below its auto components peers. The real story is margin and profit squeeze. Net profit margin over the past year sits in the mid single digits, only slightly above last...

Neurocrine Biosciences has reported Phase 4 KINECT-PRO results showing once-daily INGREZZA (valbenazine) led to substantial, sustained improvements in tardive dyskinesia patients’ quality of life, functionality and clinician-rated movement severity over 24 weeks, with safety consistent with its known profile. A unique aspect of KINECT-PRO is its use of the Neurocrine-developed Tardive Dyskinesia Impact Scale, the only validated patient-reported tool specifically for tardive dyskinesia,...

Textron stock has delivered a 5 year gain in the mid teens, yet current valuation checks suggest the market price may still sit below what the company’s cash flows and earnings would justify. With both the Discounted Cash Flow (DCF) intrinsic value estimate and earnings multiples pointing to undervaluation, recent share price softness puts the focus squarely on what investors are paying for Textron today. Textron has returned 16.4% over 5 years, which is a relatively modest payoff for...

nLIGHT (LASR) is back in focus after CEO Scott H. Keeney sold about 363,500 shares under a Rule 10b5-1 trading plan, following lowered third quarter revenue guidance tied to supply chain challenges. At a share price of $43.70, nLIGHT has seen the 30 day share price return fall 35.53% and the 90 day share price return fall 44.79%, even though the year to date share price return is 13.89% and the 1 year total shareholder return is 51.95%. This points to fading short term momentum after longer...

Wayfair (NYSE: W) plans to open its 10th physical retail store as part of its omnichannel growth strategy. The new location is intended to expand the company’s in person reach and introduce more shoppers to the Wayfair brand. The store opening is presented as a way to strengthen engagement between Wayfair’s ecommerce platform and its physical footprint. Consider widening your watchlist to include other retailers that blend online and in person models by exploring 11 dividend...

Kanzhun stock jumped 15.7% to US$18.84 into the close, which indicates traders liked what they saw. The move came after a Q2 print built on one core story. This is now a highly profitable online recruitment platform posting a net margin above 50% and an adjusted operating margin of 43.8%. The other headline is quality of earnings. Reported net income of RMB 1.9b leaned heavily on a fair value gain from an investee’s IPO. That lifts the headline numbers today. Long term holders will focus on...

Long term U.S. yields are pressing higher, federal debt has moved beyond $40t, and the Treasury is stepping up bond buybacks as confidence in the dollar wobbles and traders look harder at gold and Bitcoin. That mix is reshaping how crypto exchanges and infrastructure platforms are viewed. This article walks through three stocks from our screener that appear especially exposed to these cross currents right now. The three stocks below are just a starting sample, since the full screen surfaced...

Earlier this week, Thermo Fisher Scientific launched the Thermo Scientific Orbitrap Isora and Isora Pro mass spectrometers, integrating them with the Vanquish Duo UHPLC System and new Isotope Discoverer Software to enable molecular-level isotope ratio analysis across fields from environmental science to food authenticity. The workflow’s ability to capture multiple isotopes from intact molecules in a single run, turning previously complex, multi-step analyses into results within hours, could...

Qfin Holdings just gave investors a harsh reminder that cheap can always get cheaper. The stock dropped almost 19% to $9.35 after Q2 earnings laid bare how quickly profit can reset in a stressed China consumer credit market. Non GAAP net income landed at RMB 455m, while basic earnings per share came in at RMB 3.33. For a stock already down sharply over the past month and quarter, the headline is simple: profitability is being squeezed at the same time management is flagging a tougher second...